This study is in progress, not accepting new patients
A Study of PRT543 in Participants With Advanced Solid Tumors and Hematologic Malignancies
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Hyunseok Kang
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Hyunseok Kang
Dr.Hyunseok "Hyu" Kang is a medical oncologist and a clinician scientist focusing on head and neck cancers including squamous cell carcinomas of head and neck (SCCHN), salivary gland cancers, thyroid cancers and other rare cancers of head and neck.
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Prelude Therapeutics
- ID
- NCT03886831
- Phase
- Phase 1 research study
- Study Type
- Interventional
- Participants
- Expecting 227 study participants
- Last Updated